Wednesday, March 22, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home News Scan

Biodefense Headlines – Nov 29, 2015

by Global Biodefense Staff
November 29, 2015
Headlines of the Week in Biodefense

See what we’re reading this week at Global Biodefense on topics including GAO’s report on BioWatch, approval of post-exposure anthrax vaccine, gene-editing and biosecurity and more…

BIODEFENSE POLICY & PRACTICES

  • Bioterror alert boxes ‘trigger false alarms’ (Sky News)
  • GAO: DHS needs to prove BioWatch pathogen-detection capabilities (CIDRAP)
  • The bioweapons convention: A new approach (BOTAS)
  • Global health experts accuse WHO of ‘egregious failure’ on Ebola (Reuters)
  • What it will take to fight the next epidemic (NY Times)
  • Biosecurity in the age of Big Data: a conversation with the FBI (MBoC)
  • This could be the next weapon of mass destruction (Quartz)
  • Panels advise bolstering W.H.O. for crises like Ebola (NY Times)
  • Ebola review calls for reforms to boost global outbreak response (CIDRAP)
  • DHS’ bioterror detection program unreliable, GAO says (HS Today)
  • Why cutting spending on public health is a false economy (The Conversation)
  • Precision Medicine Initiative and security concerns (NextGov)
  • Post-Ebola: how can the WHO get back its teeth? (MNT)
  • Top biologists debate ban on gene-editing (The Guardian)

CHEMICAL WEAPONS

  • What if Isis launches a chemical attack in Europe? (The Guardian)
  • Progress in the elimination of the Syrian chemical weapons program .pdf (OPCW)
  • Officials: ISIS determined to produce chemical weapons (Seattle Times)

SELECT AGENTS

  • This vaccine can protect you from anthrax—after exposure (Wired)
  • Amid failure and chaos, an Ebola vaccine (NY Times)
  • Puzzling Ebola death shows how little we know about the virus (NPR)
  • First-ever vaccine approved via FDA’s bioterror pathway (STAT)
  • Belgian officials say potential anthrax at Brussels mosque is false alarm (IBT)
  • FDA approves expanded use of Emergent BioSolution’s anthrax vaccine (Reuters)
  • Ebola crisis: Liberia boy dies after fresh cases (BBC News)

INFECTIOUS DISEASE COUNTERMEASURES

  • Upstate Medical gets 12M grant to develop dengue fever vaccine (Syracuse.com)
  • How do you keep vaccines cool? Try spacecraft insulation (NPR)
  • A step closer to the defeat of polio (NY Times)

OUTBREAK NEWS & THREAT SURVEILLANCE

  • Rising temperatures mean insects can carry viruses to wider areas (WP)
  • Potentially deadly virus hits Hawaii— everything you need to know (Yahoo!)
  • We’re still not ready if major outbreak happens again (Washington Post)
  • Chikungunya outbreak grows by 2,500 cases as CDC issues alerts (CIDRAP)
  • Scientists learn how to detect animal diseases threatening livestock (IAEA)
  • France detects first bird flu outbreak in eight years (Reuters)
  • America’s war on the kissing bug (The New Yorker)

RESEARCH & DEVELOPMENT

  • Inside the Pentagon’s biotech strike force (STAT)
  • ECBC scientists gain insight directly from warfighters (ECBC)
  • Grant: Emerging epidemic virus research training for West Africa (Grants.gov)
  • Mutant mosquitoes ‘resist malaria’ (BBC News)
  • CRISPR-powered malaria mosquito gene drive (The Scientist)

INDUSTRY NEWS

  • Roche pulls out of ‘superbug’ antibiotic project (Reuters)
  • The Top 100 manufacturers of point-of-care instruments and tests (MDT)
  • UK CDE hosting face-to-face meetings: 19 January 2016 (UK.gov)
  • 908 Devices recognized with industry awards handheld mass spec (BusinessWire)
  • Dx firms trickle onto stock markets (European Biotech)
  • R&D 100 CBRN Award winners (CBRNe World)

DETECTION & PROTECTION

  • PPE: Protecting health care providers in an Ebola outbreak (Clinical Therapeutics)
  • DQE releases SafePaq® Plus blood & virus protection PPE kit (GSN)
  • Bringing the gold standard to the front line (Domestic Preparedness)

EDUCATION & TRAINING

  • GMU Biodefense: Bridging the gap between science and policy (George Mason University)
  • Emerging Leaders in Biosecurity fellowship (UPMC Center for Health Security)
  • DHS Agricultural Defense Branch internship opportunity (IIAD)

RADIOLOGICAL & NUCLEAR THREATS

  • Perry warns against the dangers of a nuclear ISIS (CISAC)
  • New IAEA Safety Standards Reinforce Emergency Preparedness (IAEA)
  • Mass casualty decon in a chemical or radiological/nuclear incident (PLOS)
  • New technologies and the nuclear threat (Carnegie)

HISTORICAL REFLECTIONS

  • A history of influenza pandemics (Texas A&M)
  • I am thankful for Jonas Salk (Tracking Zebra)

Related Posts

Biodefense Headlines – 12 March 2023
News Scan

Biodefense Headlines – 12 March 2023

March 12, 2023
Biodefense Headlines – 24 January 2023
News Scan

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023
News Scan

Biodefense Headlines – 17 January 2023

January 17, 2023
Biodefense Headlines – 10 January 2023
News Scan

Biodefense Headlines – 10 January 2023

January 10, 2023
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy